FI923364A - Foerfarande foer framstaellning av en farmaceutisk sammansaettning som paoverkar det retikuloendotela systemet - Google Patents

Foerfarande foer framstaellning av en farmaceutisk sammansaettning som paoverkar det retikuloendotela systemet Download PDF

Info

Publication number
FI923364A
FI923364A FI923364A FI923364A FI923364A FI 923364 A FI923364 A FI 923364A FI 923364 A FI923364 A FI 923364A FI 923364 A FI923364 A FI 923364A FI 923364 A FI923364 A FI 923364A
Authority
FI
Finland
Prior art keywords
framework
acid
acidic
neutral
pharmaceutically acceptable
Prior art date
Application number
FI923364A
Other languages
English (en)
Finnish (fi)
Other versions
FI923364A0 (fi
Inventor
Jozsef Beres
Jr Jozsef Beres
Original Assignee
Beres Export Import Rt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beres Export Import Rt filed Critical Beres Export Import Rt
Publication of FI923364A0 publication Critical patent/FI923364A0/fi
Publication of FI923364A publication Critical patent/FI923364A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Circuits Of Receivers In General (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Catching Or Destruction (AREA)
  • Percussion Or Vibration Massage (AREA)
FI923364A 1991-07-24 1992-07-24 Foerfarande foer framstaellning av en farmaceutisk sammansaettning som paoverkar det retikuloendotela systemet FI923364A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU912492A HU207799B (en) 1991-07-24 1991-07-24 Process for producing pharmaceutical composition for influencing the reticuloendothelial system, for treating chronic pain symptomes of degenerative locomotor disorders or tumors, and for treating mucoviscidosis

Publications (2)

Publication Number Publication Date
FI923364A0 FI923364A0 (fi) 1992-07-24
FI923364A true FI923364A (fi) 1993-01-25

Family

ID=10959658

Family Applications (1)

Application Number Title Priority Date Filing Date
FI923364A FI923364A (fi) 1991-07-24 1992-07-24 Foerfarande foer framstaellning av en farmaceutisk sammansaettning som paoverkar det retikuloendotela systemet

Country Status (18)

Country Link
US (2) US5312629A (bg)
EP (1) EP0524633B1 (bg)
JP (1) JP2673852B2 (bg)
KR (1) KR100234855B1 (bg)
AT (1) ATE178213T1 (bg)
BG (1) BG61250B1 (bg)
CA (1) CA2074639C (bg)
CZ (1) CZ281672B6 (bg)
DE (1) DE69228777T2 (bg)
FI (1) FI923364A (bg)
HR (1) HRP920192B1 (bg)
HU (1) HU207799B (bg)
PL (1) PL169684B1 (bg)
RO (1) RO109505B1 (bg)
RU (1) RU2093160C1 (bg)
SI (1) SI9200155A (bg)
SK (1) SK278944B6 (bg)
YU (1) YU48243B (bg)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871779A (en) * 1994-01-18 1999-02-16 Mount Sinai Hospital Corporation Treatment of arthropathies with vanadate compounds or analogues thereof
US5843481A (en) * 1994-01-18 1998-12-01 Mount Sinai Hospital Corporation Treatment of proliferative disorders, metastasaes, and drug resistant tumors with vanadate compounds and derivatives or analogues thereof
US5863519A (en) * 1994-08-18 1999-01-26 Nycomed Imaging As Composition and method of MRI using both a positive and a negative contrast agent
GB9416768D0 (en) * 1994-08-18 1994-10-12 Nycomed Innovation Ab Compositions
GB9416767D0 (en) * 1994-08-18 1994-10-12 Nycomed Innovation Ab Compositions
WO1996005867A2 (en) * 1994-08-18 1996-02-29 Nycomed Imaging A/S Compositions
FR2740342B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, de manganese, de lithium, d'etain, de zinc ou d'yttrium, de cobalt, de baryum, de strontium dans des compositions pharmaceutiques
RU2146146C1 (ru) * 1999-05-05 2000-03-10 Дубинина Лариса Васильевна Репаративно-регенеративный препарат, способ его изготовления и лечебного использования по л.в.дубининой
US20030170318A1 (en) * 2000-09-29 2003-09-11 Steiner Gregory Gene Fluoride compositions and uses thereof
US6638431B2 (en) * 2001-05-03 2003-10-28 Mainstream Engineering Corporation Formulation and method for treating wetted surface elements in climate control systems
KR100889994B1 (ko) * 2003-08-14 2009-03-24 한영미 녹반을 함유하는 항암활성을 갖는 조성물
KR20050018250A (ko) * 2003-08-14 2005-02-23 한영주 복합생약 조성물을 함유하는 항암활성을 갖는 조성물
US20060134227A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Compositions including iron
WO2006130027A1 (en) * 2005-05-31 2006-12-07 Santos Ma Joyce Bedelia B Aqueous oral liquid vitamin supplements containing stabilized vitamin c and metal ions
US20090214500A1 (en) * 2005-06-02 2009-08-27 U.S. Borax Inc. Prevention and treatment of osteochondrosis in animals and humans
MX2009005965A (es) * 2006-12-06 2009-06-17 United States Borax Inc Composiciones de alimento para animales.
US8008035B2 (en) 2007-01-25 2011-08-30 Roche Diagnostics Operations, Inc. Enhancement of vanadium-containing phosphatase inhibitors
EP1949894B1 (en) * 2007-01-25 2016-06-29 Roche Diagnostics GmbH Enhancement of vanadium-containing phosphatase inhibitors by polyols
US10634385B2 (en) 2009-09-03 2020-04-28 Ademco Inc. Heat balancing system
CN115927242A (zh) 2012-05-11 2023-04-07 珍白斯凯尔有限公司 具有抗炎活性的肽及其在制备抗炎组合物中的应用
WO2014010971A1 (ko) 2012-07-11 2014-01-16 주식회사 카엘젬백스 세포 투과성 펩티드, 그를 포함한 컨쥬게이트 및 그를 포함한 조성물
CA2912557A1 (en) 2013-06-07 2014-12-11 Gemvax & Kael Co., Ltd. Biological markers useful in cancer immunotherapy
EP3011967B1 (en) 2013-06-21 2020-06-17 Gemvax & Kael Co., Ltd. Hormone secretion regulator, composition containing same, and method for controlling hormone secretion using same
KR102314231B1 (ko) 2013-12-17 2021-10-19 주식회사 젬백스앤카엘 전립선 암 치료용 조성물
WO2015126265A1 (en) * 2014-02-18 2015-08-27 Santos Joyce Bedelia B Oral liquid vitamin supplements containing zinc and stabilized vitamin c with reduced astringency
CN106456697B (zh) 2014-04-11 2019-12-17 珍白斯凯尔有限公司 具有纤维化抑制活性的肽和含有其的组合物
EP3138399B1 (en) 2014-04-30 2023-09-06 Gemvax & Kael Co., Ltd. Composition for organ, tissue, or cell transplantation, kit, and transplantation method
KR102413243B1 (ko) 2014-12-23 2022-06-27 주식회사 젬백스앤카엘 안질환 치료 펩티드 및 이를 포함하는 안질환 치료용 조성물
CN107405380B (zh) 2015-02-27 2021-04-20 珍白斯凯尔有限公司 用于预防听觉损伤的肽及其包含该肽的组合物
KR102638286B1 (ko) 2015-07-02 2024-02-20 주식회사 젬백스앤카엘 항바이러스 활성 효능을 가지는 펩티드 및 이를 포함하는 조성물
CN109328068A (zh) 2016-04-07 2019-02-12 珍白斯凯尔有限公司 具有增加端粒酶活性和延长端粒的效果的肽以及包含该肽的组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2022998B (en) * 1978-06-14 1982-09-08 Beres J Phermaceutical composition for the treatment of neoplasticand other diseases
JPS554348A (en) * 1978-06-26 1980-01-12 Peresu Yozefu Drug composition for treating variety of illness by influence to reticuloendotherial tissue and method of treating maligmant tumor with said composition in treating human

Also Published As

Publication number Publication date
JP2673852B2 (ja) 1997-11-05
YU81092A (sr) 1996-01-09
SK232692A3 (en) 1995-06-07
EP0524633A3 (en) 1993-07-28
HU207799B (en) 1993-06-28
PL169684B1 (pl) 1996-08-30
EP0524633A2 (en) 1993-01-27
CA2074639C (en) 1996-01-09
HUT61475A (en) 1993-01-28
HRP920192A2 (hr) 1994-04-30
PL295352A1 (en) 1993-02-22
US5312629A (en) 1994-05-17
SI9200155A (en) 1993-03-31
ATE178213T1 (de) 1999-04-15
CA2074639A1 (en) 1993-01-25
FI923364A0 (fi) 1992-07-24
RO109505B1 (ro) 1995-03-30
RU2093160C1 (ru) 1997-10-20
DE69228777T2 (de) 1999-10-21
HRP920192B1 (en) 2000-06-30
BG96686A (bg) 1993-12-24
JPH06227992A (ja) 1994-08-16
CZ281672B6 (cs) 1996-12-11
US5405620A (en) 1995-04-11
KR930001915A (ko) 1993-02-22
EP0524633B1 (en) 1999-03-31
CZ232692A3 (en) 1993-02-17
SK278944B6 (sk) 1998-05-06
YU48243B (sh) 1997-08-22
KR100234855B1 (ko) 1999-12-15
BG61250B1 (bg) 1997-04-30
HU912492D0 (en) 1991-12-30
DE69228777D1 (de) 1999-05-06

Similar Documents

Publication Publication Date Title
FI923364A (fi) Foerfarande foer framstaellning av en farmaceutisk sammansaettning som paoverkar det retikuloendotela systemet
AU2054097A (en) Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents
GR3030342T3 (en) Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase.
AU8110098A (en) A process for the preparation of macrocyclic chelants and the chelates thereof with paramagnetic metal ions
EP0543015A4 (en) Composition, method and kit for potentiating antitumor activity and for curing tumor
AU5996996A (en) Al/fe-treatment of a protein solution, followed by membrane concentration
CA2020858A1 (en) Water treatment agent and water treatment method for boiler
DE69323229D1 (de) Verfahren zur Bekämpfung von Bakterien-/Pilzkrankheiten in Pflanzen
GR1002573B (el) Μικροβιακη μεθοδος παρασκευης μεβινολινης.
YU41800B (en) Process for the purification of gallium solutions
ES8303440A1 (es) "procedimiento para la preparacion de acidos oxazafosforin-4-tio-alcansulfonicos".
CA2022187A1 (en) N,n-bis-phosphonomethyl taurine n-oxide and water-soluble salts thereof
EP0415119A3 (en) Process for continuously removing and recovering complexing compounds from process water
DE69837219D1 (de) 1,4,7,10-tetraazacyclododecan-1,4-diessigsäure
ES8701185A1 (es) Un procedimiento para preparar un complejo metalico farma- ceuticamente aceptable de un compuesto bis-indolico
AU5214900A (en) Pressed products of non-caking salt
Patwardhan Glutamic-aspartic transaminase of Dolichos lablab: participation by iron as a cofactor
ES8602676A1 (es) Un procedimiento para la preparacion de nuevos derivados de pirrolo-(2,1-a)isoquilonina.
GB1364917A (en) Preparation of 1h-tetrazole compounds
ES2044777A1 (es) Procedimiento de obtencion de un quelato de hierro de gran solubilidad.
RU94046263A (ru) Способ удаления железа из фосфорной кислоты, полученной мокрым способом
HUP9801499A2 (hu) Metasztázisgátló gyógyászati készítmény és eljárás ennek előállítására
GB1216388A (en) A process for purifying amino acids
GB0008179D0 (en) Chemical process
FR2646348B1 (bg)

Legal Events

Date Code Title Description
FD Application lapsed